Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

Announcing: The 1.05 Contest

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (8) | Next 10 | Previous | Next
JG36 Member Profile
 
Followed By 10
Posts 4,605
Boards Moderated 0
Alias Born 11/12/12
160x600 placeholder
NanoViricides reports strong pre-clinical data for COVID-19 drugs Seeking Alpha - 3/9/2021 11:26:50 AM
NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in ....Cont InvestorsHub NewsWire - 3/9/2021 9:30:00 AM
NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical InvestorsHub NewsWire - 3/2/2021 7:00:08 AM
NanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studies Seeking Alpha - 3/2/2021 6:43:58 AM
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug ....cont InvestorsHub NewsWire - 2/17/2021 7:00:00 AM
NanoViricides reports FQ2 results Seeking Alpha - 2/17/2021 6:28:57 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:40:48 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 9:48:43 AM
NanoViricides’s anti-coronavirus candidate was well tolerated in animal studies Seeking Alpha - 2/8/2021 6:46:46 AM
NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP..C... InvestorsHub NewsWire - 2/8/2021 6:36:27 AM
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants InvestorsHub NewsWire - 1/27/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/26/2021 11:05:24 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/4/2021 11:45:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2020 4:31:33 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/3/2020 4:31:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2020 4:53:44 PM
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA InvestorsHub NewsWire - 11/19/2020 6:47:01 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:33:46 PM
NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 InvestorsHub NewsWire - 11/11/2020 7:14:53 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/26/2020 4:25:50 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/13/2020 5:23:45 PM
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19 InvestorsHub NewsWire - 9/16/2020 7:17:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 5:20:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/31/2020 5:30:54 PM
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020 InvestorsHub NewsWire - 7/21/2020 9:42:43 AM
JG36   Wednesday, 08/05/15 10:57:17 AM
Re: None
Post # of 145298 
Announcing: The 1.05 Contest

Give the date you think NNVC will close at or below 1.05.

The winner is the one who comes closest in trading days.

You may guess "Never". The contest ends March 31, 2016. If the price never closes at or below 1.05 between now and March 31 those who guessed "Never" win.

If there is a reverse split the target price will be adjusted accordingly. E.g., if the reverse split is 2 shares -> 1 share than then target becomes 2.10.

The rewards are the usual ones: Bragging rights for the winner, along with universal commiseration if he is long and universal spiteful envy if he is short.

Entries must be made by midnight EDT, Friday, August 14, 2015.

Note: 1.05 = 0.30 pre-split.

My entry:

JG36: December 10.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (8) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences